4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression

Details for Australian Patent Application No. 2008228639 (hide)

Owner H. Lundbeck A/S

Inventors Stensbol, Tine Bryan; Miller, Silke

Agent Watermark

Pub. Number AU-A-2008228639

PCT Pub. Number WO2008/113360

Priority PCT/ DK2007/050076 15.06.07 DK; PA200700423 20.03.07 DK

Filing date 14 March 2008

Wipo publication date 25 September 2008

International Classifications

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 211/20 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/113360 Priority application(s): WO2008/113360

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228646-Method and system for custom tailoring and retailing of clothing

2008228638-1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition